Sanofi appoints head of strategy
pharmafile | July 28, 2011 | Appointment | Sales and Marketing | appointment, sales and marketing
Dr David-Alexandre Gros has joined Sanofi as chief strategy officer with a remit that covers all the group’s business development and acquisition activities.
He will also oversee strategic planning, economic evaluation of projects, strategic intelligence and alliance management at the French pharma company.
Sanofi’s chief executive Christopher Viehbacher said: “David-Alexandre brings a wealth of experience as a physician, strategic consultant and investment banker.
“He will be able to contribute significantly to the development and implementation of Sanofi’s strategy and transformation.”
David-Alexandre joins Sanofi after serving as an advisor to pharmaceutical, biotechnology and diagnostic companies as a principal and founding member of the Healthcare Investment Banking division at Centerview Partners, in San Francisco, California.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






